查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1420953

輔助生殖技術市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Assisted Reproductive Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 189 Pages | 商品交期: 2-10個工作天內

價格

輔助生殖技術市場 - 報告範圍

TMR 關於全球輔助生殖技術市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球輔助生殖技術的收入2017-2031年期間的市場，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球輔助生殖技術市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解輔助生殖技術市場。

市場概況
2023年市場價值 259 億美元
2031 年市場價值 586 億美元
CAGR 9.4%

該報告深入探討了全球輔助生殖技術市場的競爭格局。全球輔助生殖技術市場的主要參與者已被確定，並且每個參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球輔助生殖技術市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 關鍵技術/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依技術分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依技術分類，2017-2031
    • 體外受精
      • 胞漿內單一精子注射 (ICSI)
      • 植入前遺傳學診斷（PGD）
    • 人工授精
      • 子宮內人工授精 (IUI)
      • 子宮頸內人工授精 (ICI)
      • 其他
    • 代孕
    • 其他
  • 市場吸引力分析：依技術分類

第 7 章：全球市場分析與預測：按程序

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按程序，2017-2031
    • 冷凍供體
    • 凍結非捐贈者
    • 新的捐贈者
    • 新鮮的非捐贈者
    • 胚胎銀行
  • 市場吸引力分析：按程序

第 8 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 生育診所
    • 醫院
    • 其他
  • 市場吸引力分析：按最終用戶

第 9 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 10 章：北美市場分析與預測

第 11 章：歐洲市場分析與預測

第 12 章：亞太市場分析與預測

第 13 章：拉丁美洲市場分析與預測

第 14 章：中東和非洲市場分析與預測

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • Merck KGaA
    • CooperSurgical, Inc.
    • FUJIFILM Irvine Scientific
    • Vitrolife AB
    • Hamilton Thorne, Inc.
    • Nikon Corporation
    • Nidacon International AB
    • Laboratoire CCD
    • Esco Micro Pte. Ltd.
Product Code: TMRGL29234

Assisted Reproductive Technology Market - Scope of Report

TMR's report on the global assisted reproductive technology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global assisted reproductive technology market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global assisted reproductive technology market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the assisted reproductive technology market.

Market Snapshot
Market Value in 2023US$ 25.9 Bn
Market Value in 2031US$ 58.6 Bn
CAGR9.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global assisted reproductive technology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global assisted reproductive technology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global assisted reproductive technology market.

The report delves into the competitive landscape of the global assisted reproductive technology market. Key players operating in the global assisted reproductive technology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global assisted reproductive technology market profiled in this report.

Key Questions Answered in Global assisted reproductive technology Market Report:

  • What is the sales/revenue generated by assisted reproductive technology across all regions during the forecast period?
  • What are the opportunities in the global assisted reproductive technology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Assisted Reproductive Technology Market - Research Objectives and Research Approach

The comprehensive report on the global assisted reproductive technology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global assisted reproductive technology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global assisted reproductive technology market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Assisted Reproductive Technology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Technology Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Assisted Reproductive Technology Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Technology/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Assisted Reproductive Technology Market Analysis and Forecast, by Technology

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Technology, 2017-2031
    • 6.3.1. In Vitro Fertilization
      • 6.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 6.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 6.3.2. Artificial Insemination
      • 6.3.2.1. Intrauterine Insemination (IUI)
      • 6.3.2.2. Intracervical Insemination (ICI)
      • 6.3.2.3. Others
    • 6.3.3. Surrogacy
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Technology

7. Global Assisted Reproductive Technology Market Analysis and Forecast, by Procedure

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Procedure, 2017-2031
    • 7.3.1. Frozen Donor
    • 7.3.2. Frozen Non-donor
    • 7.3.3. Fresh Donor
    • 7.3.4. Fresh Non-donor
    • 7.3.5. Embryo Banking
  • 7.4. Market Attractiveness Analysis, by Procedure

8. Global Assisted Reproductive Technology Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Fertility Clinics
    • 8.3.2. Hospitals
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Assisted Reproductive Technology Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Assisted Reproductive Technology Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Technology, 2017-2031
    • 10.3.1. In Vitro Fertilization
      • 10.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 10.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 10.3.2. Artificial Insemination
      • 10.3.2.1. Intrauterine Insemination (IUI)
      • 10.3.2.2. Intracervical Insemination (ICI)
      • 10.3.2.3. Others
    • 10.3.3. Surrogacy
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Procedure, 2017-2031
    • 10.4.1. Frozen Donor
    • 10.4.2. Frozen Non-donor
    • 10.4.3. Fresh Donor
    • 10.4.4. Fresh Non-donor
    • 10.4.5. Embryo Banking
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Fertility Clinics
    • 10.5.2. Hospitals
    • 10.5.3. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Technology
    • 10.7.2. By Procedure
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Assisted Reproductive Technology Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Technology, 2017-2031
    • 11.3.1. In Vitro Fertilization
      • 11.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 11.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 11.3.2. Artificial Insemination
      • 11.3.2.1. Intrauterine Insemination (IUI)
      • 11.3.2.2. Intracervical Insemination (ICI)
      • 11.3.2.3. Others
    • 11.3.3. Surrogacy
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Procedure, 2017-2031
    • 11.4.1. Frozen Donor
    • 11.4.2. Frozen Non-donor
    • 11.4.3. Fresh Donor
    • 11.4.4. Fresh Non-donor
    • 11.4.5. Embryo Banking
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Fertility Clinics
    • 11.5.2. Hospitals
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Technology
    • 11.7.2. By Procedure
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Assisted Reproductive Technology Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Technology, 2017-2031
    • 12.3.1. In Vitro Fertilization
      • 12.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 12.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 12.3.2. Artificial Insemination
      • 12.3.2.1. Intrauterine Insemination (IUI)
      • 12.3.2.2. Intracervical Insemination (ICI)
      • 12.3.2.3. Others
    • 12.3.3. Surrogacy
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Procedure, 2017-2031
    • 12.4.1. Frozen Donor
    • 12.4.2. Frozen Non-donor
    • 12.4.3. Fresh Donor
    • 12.4.4. Fresh Non-donor
    • 12.4.5. Embryo Banking
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Fertility Clinics
    • 12.5.2. Hospitals
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Technology
    • 12.7.2. By Procedure
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Assisted Reproductive Technology Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Technology, 2017-2031
    • 13.3.1. In Vitro Fertilization
      • 13.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 13.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 13.3.2. Artificial Insemination
      • 13.3.2.1. Intrauterine Insemination (IUI)
      • 13.3.2.2. Intracervical Insemination (ICI)
      • 13.3.2.3. Others
    • 13.3.3. Surrogacy
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Procedure, 2017-2031
    • 13.4.1. Frozen Donor
    • 13.4.2. Frozen Non-donor
    • 13.4.3. Fresh Donor
    • 13.4.4. Fresh Non-donor
    • 13.4.5. Embryo Banking
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Fertility Clinics
    • 13.5.2. Hospitals
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Technology
    • 13.7.2. By Procedure
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Assisted Reproductive Technology Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Technology, 2017-2031
    • 14.3.1. In Vitro Fertilization
      • 14.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
      • 14.3.1.2. Preimplantation Genetic Diagnosis (PGD)
    • 14.3.2. Artificial Insemination
      • 14.3.2.1. Intrauterine Insemination (IUI)
      • 14.3.2.2. Intracervical Insemination (ICI)
      • 14.3.2.3. Others
    • 14.3.3. Surrogacy
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Procedure, 2017-2031
    • 14.4.1. Frozen Donor
    • 14.4.2. Frozen Non-donor
    • 14.4.3. Fresh Donor
    • 14.4.4. Fresh Non-donor
    • 14.4.5. Embryo Banking
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Fertility Clinics
    • 14.5.2. Hospitals
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Technology
    • 14.7.2. By Procedure
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Merck KGaA
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Technology Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. CooperSurgical, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Technology Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. FUJIFILM Irvine Scientific
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Technology Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Vitrolife AB
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Technology Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Hamilton Thorne, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Technology Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Nikon Corporation
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Technology Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Nidacon International AB
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Technology Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Laboratoire CCD
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Technology Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Esco Micro Pte. Ltd.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Technology Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 02: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 03: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 07: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 08: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 11: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 12: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 15: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 16: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 19: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 20: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 23: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 24: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Assisted Reproductive Technology Market Size (US$ Mn) and Distribution (%), by Region, 2017 and 2031
  • Figure 02: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Technology, 2022
  • Figure 03: Global Assisted Reproductive Technology Market Value Share, by Technology, 2022
  • Figure 04: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Procedure, 2022
  • Figure 05: Global Assisted Reproductive Technology Market Value Share, by Procedure, 2022
  • Figure 06: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by End-user, 2022
  • Figure 07: Global Assisted Reproductive Technology Market Value Share, by End-user, 2022
  • Figure 08: Global Assisted Reproductive Technology Market Value Share, by Region, 2022
  • Figure 09: Global Assisted Reproductive Technology Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 10: Global Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 11: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 12: Global Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 13: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 14: Global Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 15: Global Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 16: Global Assisted Reproductive Technology Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 17: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 18: North America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 19: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Assisted Reproductive Technology Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 21: North America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 22: North America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 23: North America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 24: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 25: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 26: North America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Europe Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 30: Europe Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 31: Europe Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 32: Europe Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 33: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 34: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 35: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 36: Asia Pacific Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 37: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 39: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 40: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 41: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 42: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 43: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 44: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Latin America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 46: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 48: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 49: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 50: Latin America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 51: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 52: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 53: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 55: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 57: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 58: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 59: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 60: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 61: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 62: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023-2031